Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
6.06
+0.30 (5.25%)
Dec 24, 2024, 12:57 PM EST - Market closed

Pulmatrix Revenue

Pulmatrix had revenue of $366.00K in the quarter ending September 30, 2024, a decrease of -79.12%. This brings the company's revenue in the last twelve months to $10.01M, up 47.05% year-over-year. In the year 2023, Pulmatrix had annual revenue of $7.30M with 20.21% growth.

Revenue (ttm)
$10.01M
Revenue Growth
+47.05%
P/S Ratio
2.21
Revenue / Employee
$454,773
Employees
22
Market Cap
22.14M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.30M1.23M20.21%
Dec 31, 20226.07M902.00K17.45%
Dec 31, 20215.17M-7.47M-59.09%
Dec 31, 202012.63M4.72M59.72%
Dec 31, 20197.91M7.76M5,069.93%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
HOOKIPA Pharma 50.00M
Equillium 45.91M
BioLineRx 21.99M
Vivos Therapeutics 14.58M
NeurAxis 2.46M
iBio, Inc. 175.00K
Gelteq 95.62K
Revenue Rankings